Enzo Biochem Reports Second Quarter Fiscal Year 2023 Financial Results
March 21, 2023 09:43 ET
|
Enzo Biochem, Inc.
- Company entered into an Asset Purchase Agreement for substantially all of the operating assets of the Clinical Labs division - Enzo Life Sciences reports revenue of $7.5 million, with Jan-23...
Enzo Biochem Agrees to Sell Clinical Laboratory to Labcorp
March 16, 2023 16:30 ET
|
Enzo Biochem, Inc.
Significant value unlocked for Enzo shareholders with continued focus on remaining businesses. FARMINGDALE, NY, March 16, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) announced...
Enzo Biochem Reports First Quarter Fiscal Year 2023 Financial Results and Provides Business Update
December 12, 2022 17:29 ET
|
Enzo Biochem, Inc.
- Enzo Life Sciences reports revenue of $7.1 million and 9% growth in Q1 FY 2023, excluding FX - Engagement with investment bank to provide advisory services including the evaluation of strategic...
Enzo Biochem, Inc. to Report First Quarter Fiscal 2023 Financial Results and Business Update on Monday, December 12th
December 07, 2022 18:18 ET
|
Enzo Biochem, Inc.
Conference Call and Webcast Scheduled for December 13th, 8:30 AM ET New York, NY, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics...
Enzo Biochem, Inc. Announces Date of Annual Shareholders’ Meeting
November 08, 2022 18:04 ET
|
Enzo Biochem, Inc.
NEW YORK, NY, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced that its Annual Shareholders’...
Enzo Biochem, Inc. Appoints Patricia Eckert, CPA as Interim CFO
October 20, 2022 08:15 ET
|
Enzo Biochem, Inc.
NEW YORK, NY, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the appointment of Patricia...
Enzo Biochem Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update
October 14, 2022 07:30 ET
|
Enzo Biochem, Inc.
- Enzo Life Sciences reports revenue of $32.6 million and 8% growth in FY 2022, net of FX - Company successfully launched AMPIVIEW™ gene expression platform powered by LoopRNA™ ISH...
Enzo Biochem to Report Fourth Quarter 2022 Financial Results and Business Update on Friday, October 14th
October 10, 2022 11:31 ET
|
Enzo Biochem, Inc.
Conference Call and Webcast Scheduled for October 14, 2022, 8:30 am ET NEW YORK, NY, Oct. 10, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics...
Enzo Biochem, Inc. Opens Expanded Life Sciences Laboratory and Office Facilities in Farmingdale, New York
October 06, 2022 08:00 ET
|
Enzo Biochem, Inc.
100,000 square foot facility to support company plans for growth in clinical laboratory services, drug development services and product innovations Launch event to feature updates on Enzo plans for...
Enzo Biochem, Inc. Launches AMPIVIEW™ Gene Expression Platform with First Products Targeting Detection of HPV and SARS-CoV-2
September 26, 2022 08:00 ET
|
Enzo Biochem, Inc.
NEW YORK, NY, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the launch of the AMPIVIEW™...